VEGF111b, a C-terminal splice variant of VEGF-A and induced by mitomycin C, inhibits ovarian cancer growth

BACKGROUND: Alternative splicing of VEGF-A gives rise to two families – the pro-angiogenic VEGFxxx family and the anti-angiogenic VEGFxxxb family that differ by only six amino acids at their C-terminal end. The first verified and widely reported VEGFxxxb family member is VEGF165b, and here VEGF165b...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiuli, Gu, Fang, Niu, Chenguang, Wang, Yuanfen, Liu, Zhongyu, Li, Na, Pan, Bing, He, Dan, Kong, Jian, Zhang, Shaobo, Wang, Xu, Yao, Yuanqing, Zheng, Lemin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480579/
https://www.ncbi.nlm.nih.gov/pubmed/25990504
http://dx.doi.org/10.1186/s12967-015-0522-0

Ejemplares similares

Ejemplares similares